Key2Compliance is a Swedish-based pharmaceutical industry-focused startup that aims to simplify complex processes in the Life Science sector. As a member of GBA Group, the company offers comprehensive solutions in regulatory compliance, consultancy, and training. Established in 1994, Key2Compliance® and Symbioteq Kvalitet AB merged in 2020 to strengthen their offerings in the field. The company provides services ranging from medical device quality assurance, regulatory affairs, biological evaluations and toxicology, clinical development, pharma quality assurance to world-class training for the Life Science industry. With offices in Stockholm, Lund, Gothenburg, and Copenhagen, they envision becoming a leading international partner for pharmaceutical and medical device companies. The startup is yet to disclose its latest investment details, demonstrating stability and potential for future growth.
There is no investment information
No recent news or press coverage available for GBA Key2Compliance.